Ningbo David Medical Device Co., Ltd. (SHE:300314)
14.60
-0.37 (-2.47%)
Nov 13, 2026, 3:04 PM CST
SHE:300314 Revenue
Ningbo David Medical Device had revenue of 169.39M CNY in the quarter ending September 30, 2026, with 19.80% growth. This brings the company's total for the last twelve months to 612.67M, up 18.56% year-over-year. In the year 2025, Ningbo David Medical Device had annual revenue of 584.03M with 10.82% growth. That makes Ningbo David Medical Device the 23,335th largest company in the world by revenue and 4,211th in China.
Revenue (ttm)
612.67M
Revenue Growth
+18.56%
P/S Ratio
6.86
Revenue / Employee
665.95K
Employees
920
Market Cap
4.20B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:300314 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 584.03M | 57.00M | 10.82% |
| Dec 31, 2024 | 527.03M | -91.27M | -14.76% |
| Dec 31, 2023 | 618.30M | 112.26M | 22.18% |
| Jan 1, 2023 | 506.04M | 31.90M | 6.73% |
| Jan 1, 2022 | 474.13M | 14.60M | 3.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Huakang Century Clean Technology | 2.63B |
| BMC Medical | 1.44B |
| Shenzhen Lifotronic Technology | 1.20B |
| Getein Biotech | 1.11B |
| SWS Hemodialysis Care | 959.44M |
| Shanghai Aohua Photoelectricity Endoscope | 806.07M |
| Shanghai Kinetic Medical | 734.04M |
| Shanghai Sanyou Medical | 591.46M |